Judgment of the Supreme Court of Justice of 07/03/2023, case no. 174/21.7YHLSB.L1.S1 | ECLI:PT:STJ:2023:174.21.7YHLSB.L1.S1.85
,
Portugal
RetourDate du jugement7 mars 2023JuridicitonCour suprêmeDegrés de juridictionInstance finaleType de procédureJudiciaire (civil)SujetBrevets (Inventions)Plaignant/RequérantDANA-FARBER CANCER INSTITUTE, INC DéfendeurInstituto Nacional da Propriedade IndustrialMots clés
Patent,
Medical product,
Supplementary protection,
Regulation,
Court of Justice of the European Union,
European Union law
Jugement/DécisionPortugaisAcórdão do Supremo Tribunal de Justiça de 07/03/2023, processo n.º 174/21.7YHLSB.L1.S1 | ECLI:PT:STJ:2023:174.21.7YHLSB.L1.S1.85
PDFHTMLRésuméPortugaisAcórdão do Supremo Tribunal de Justiça de 07/03/2023, processo n.º 174/21.7YHLSB.L1.S1 | ECLI:PT:STJ:2023:174.21.7YHLSB.L1.S1.85
PDFHTMLLégislation pertinente